Source: Contract Pharma

ABITEC: Abitec Expands Custom Synthesis Capabilities

Introduces a service providing comprehensive custom lipid synthesis capabilities for LNP therapeutics.

Read full article »
ABITEC's Competitors | ABITEC's News | ABITEC's Financials
Stay up-to-date with the latest news on ABITEC
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jeff Walton's photo - CEO of ABITEC

CEO

Jeff Walton

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on ABITEC